<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08436593830755</udiDi>
    <basicUdiDi>843659383TAS123LX</basicUdiDi>
    <tradeName>Tasectan 500 mg</tradeName>
    <deviceName>Tasectan capsules</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G99</emdnCode>
    <emdnDescription>GASTROINTESTINAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1311364</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:33.958Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436593830304</udiDi>
    <basicUdiDi>843659383TAS123LX</basicUdiDi>
    <tradeName>Tasectan 500 mg</tradeName>
    <deviceName>Tasectan capsules</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G99</emdnCode>
    <emdnDescription>GASTROINTESTINAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1308534</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:31.546Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436593830298</udiDi>
    <basicUdiDi>843659383TAS133M2</basicUdiDi>
    <tradeName>Tasectan 250 mg</tradeName>
    <deviceName>Tasectan sachets</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G99</emdnCode>
    <emdnDescription>GASTROINTESTINAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1308533</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:30.344Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436593830151</udiDi>
    <basicUdiDi>843659383TAS123LX</basicUdiDi>
    <tradeName>Tasectan 15 capsules</tradeName>
    <deviceName>Tasectan capsules</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G99</emdnCode>
    <emdnDescription>GASTROINTESTINAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1308500</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:23.165Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436593830144</udiDi>
    <basicUdiDi>843659383TAS133M2</basicUdiDi>
    <tradeName>Tasectan 20 sachets</tradeName>
    <deviceName>Tasectan sachets</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G99</emdnCode>
    <emdnDescription>GASTROINTESTINAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1308499</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:21.956Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436593830090</udiDi>
    <basicUdiDi>843659383TAS133M2</basicUdiDi>
    <tradeName>Gelenterum 250 mg</tradeName>
    <deviceName>Tasectan sachets</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G99</emdnCode>
    <emdnDescription>GASTROINTESTINAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1308490</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:20.744Z</lastUpdated>
  </row>
</eudamedExport>